Seaport Therapeutics Inc. (SPTX) Stock Price, Quote & News

Company Profile

Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform. The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations or hepatotoxicity and other side effects. All therapeutic candidates in develo...

Industry: Biotechnology

Sector: Healthcare

Phone: (617) 807-4062

Website: www.seaporttx.com

Address:

101 Seaport Blvd., Floor 12, Boston, United States

TATTED_KEN May. 14 at 4:35 PM

$SPTX so far so good Sitting in my IRA. Long-term target $50 🎯

0 · Reply

unbreakable01 May. 6 at 4:30 PM

$SPTX buying this now, will reap a ton on returns.

0 · Reply

amazingcrwns May. 6 at 3:14 PM

$SPTX I wonder if they'll have better luck than Lipocine. Seems like a similar drug delivery technology. I don't know if Glyph has any advantages or disadvantages compared to Lip'ral, but I'm curious how their drug trials will play out. I'm not ready to invest, but good luck to those that do.

0 · Reply

TATTED_KEN May. 5 at 1:03 PM

$SPTX adding to my IRA. 10% owner just filed for 1.1M shares at a $20M valuation. I see this moving over $50 soon.

0 · Reply

theflynews May. 4 at 3:49 PM

Opening Day: Pershing Square listings open soft in market debut - $SPTX - https://thefly.com/SPTX

0 · Reply

cavinsin May. 3 at 4:40 PM

$SPTX I am very confident to invest in this company Foprmer CEO of Intra Cellular Therapies, Sharon Mates has joined this team, Check what ITCI did in 5 years under her command, Amazing, from $10 to $ 130 GL to all

0 · Reply